Prudential Financial Inc. bought a new position in Ardent Health Partners, LLC (NYSE:ARDT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 28,185 shares of the company’s stock, valued at approximately $481,000.
A number of other hedge funds also recently bought and sold shares of ARDT. US Bancorp DE bought a new stake in shares of Ardent Health Partners in the 4th quarter worth approximately $31,000. R Squared Ltd purchased a new position in Ardent Health Partners in the 4th quarter worth $37,000. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners in the third quarter worth $42,000. New York State Common Retirement Fund purchased a new stake in Ardent Health Partners during the fourth quarter valued at about $48,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Ardent Health Partners during the third quarter valued at about $154,000.
Analyst Upgrades and Downgrades
ARDT has been the subject of several analyst reports. Stephens restated an “overweight” rating and set a $22.00 target price on shares of Ardent Health Partners in a report on Tuesday, April 1st. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Royal Bank of Canada decreased their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Guggenheim started coverage on shares of Ardent Health Partners in a research note on Wednesday. They set a “buy” rating and a $16.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Ardent Health Partners has an average rating of “Buy” and an average target price of $20.58.
Ardent Health Partners Stock Up 6.5 %
NYSE ARDT opened at $12.65 on Thursday. The stock’s 50 day moving average is $13.99 and its 200 day moving average is $15.87. Ardent Health Partners, LLC has a twelve month low of $11.60 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.
Ardent Health Partners (NYSE:ARDT – Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. On average, equities analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More
- Five stocks we like better than Ardent Health Partners
- About the Markup Calculator
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- What is the MACD Indicator and How to Use it in Your Trading
- Are Tariffs Threatening Disney’s Comeback Story?
- How to Profit From Growth Investing
- Is Alphabet a Generational Buying Opportunity at These Levels?
Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health Partners, LLC (NYSE:ARDT – Free Report).
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.